MRI-Based peritumoral radiomics for predicting recurrence risk in ER+/HER2- breast cancer.

Abstract

Authors

• Yang Chen
  Orthopedics Department of the First Affiliated Hospital of Tsinghua University, Beijing, China.
• Liang You
  Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Radiology, Peking University Cancer Hospital & Institute, Beijing, 100142, China.
• Yan Huang
  Department of Neurology, University of Texas Health Science Center at Houston, Houston, TX.
• Lizhi Xie
  GE Healthcare, MR Research China, Beijing, PR China.
• Qin Xiao
  Clinical Medical College, Yangzhou University, Yangzhou 225009, China.
• Tianwen Xie
  Department of Radiology, Fudan University Shanghai Cancer Center, 270 Dongan Road, Shanghai, 200032, China.
• Ling Zhang
• Rong Li
  Department of Neurology, People's Hospital of Longhua, Shenzhen, China.
• Qifeng Wang
  Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China.
• Yingshi Sun
  Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Radiology, Peking University Cancer Hospital & Institute, Beijing, 100142, China. [email protected].
• Wei Tang
  Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
• Yajia Gu
  Department of Radiology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China. [email protected].
• Weijun Peng
  Department of Radiology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.

Keywords

No keywords available for this article.

External Resources